107 related articles for article (PubMed ID: 10625958)
1. Influence of ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane (AOM).
Tsuda H; Park CB; Takasuka N; Baba-Toriyama H; Sekine K; Moore MA; Nomura E; Taniguchi H
Anticancer Res; 1999; 19(5A):3779-82. PubMed ID: 10625958
[TBL] [Abstract][Full Text] [Related]
2. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
3. A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.
Han BS; Park CB; Takasuka N; Naito A; Sekine K; Nomura E; Taniguchi H; Tsuno T; Tsuda H
Jpn J Cancer Res; 2001 Apr; 92(4):404-9. PubMed ID: 11346462
[TBL] [Abstract][Full Text] [Related]
4. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
5. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
12. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.
Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H
Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis.
Mori H; Kawabata K; Yoshimi N; Tanaka T; Murakami T; Okada T; Murai H
Anticancer Res; 1999; 19(5A):3775-8. PubMed ID: 10625957
[TBL] [Abstract][Full Text] [Related]
16. Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats.
Katyama M; Yoshimi N; Yamada Y; Sakata K; Kuno T; Yoshida K; Qiao Z; Vihn PQ; Iwasaki T; Kobayashi H; Mori H
Oncol Rep; 2002; 9(4):817-22. PubMed ID: 12066215
[TBL] [Abstract][Full Text] [Related]
17. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
18. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats.
Williams D; Verghese M; Walker LT; Boateng J; Shackelford L; Chawan CB
Food Chem Toxicol; 2007 Jan; 45(1):153-9. PubMed ID: 17045379
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats.
Bunpo P; Kataoka K; Arimochi H; Nakayama H; Kuwahara T; Bando Y; Izumi K; Vinitketkumnuen U; Ohnishi Y
Food Chem Toxicol; 2004 Dec; 42(12):1987-97. PubMed ID: 15500935
[TBL] [Abstract][Full Text] [Related]
20. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
